Peptide Graded

Abaloparatide

Is Abaloparatide legal in the US?

Yes, FDA approved for thin bones (osteoporosis) in women after menopause and in men.

AStrong human evidenceFDA approvedas of 2026-10-26

Abaloparatide is FDA-approved and sold as Tymlos, a once-daily subcutaneous injection. It was approved in April 2017 for postmenopausal women with osteoporosis at high risk of fracture and in December 2022 to increase bone density in men with osteoporosis at high risk of fracture. 67

Yes. Tymlos was approved in 2017 for postmenopausal women with osteoporosis at high risk of fracture. In December 2022 it was approved for men with osteoporosis at high risk of fracture. 67

Read the full Abaloparatide page

More on Abaloparatide

Citations

  1. StatPearls: Abaloparatide ncbi.nlm.nih.gov
  2. PMC review: PTH1 receptor pharmacology of abaloparatide pmc.ncbi.nlm.nih.gov
  3. StatPearls: Physiology, bone remodeling ncbi.nlm.nih.gov
  4. NIAMS: Bone mineral density tests, what the numbers mean niams.nih.gov
  5. Miller 2016, JAMA: ACTIVE trial of abaloparatide vs placebo in postmenopausal osteoporosis jamanetwork.com
  6. FDA: Tymlos (abaloparatide) prescribing information, 2024 accessdata.fda.gov
  7. Radius Health: Tymlos product site tymlos.com
  8. Biochemical Pharmacology 2019: abaloparatide, a first-in-class PTHrP analog sciencedirect.com

Reference information only, not medical advice. Drawn from the Abaloparatide article, fact-checked against the cited sources. No dosing anywhere on this site.